Literature DB >> 27407728

Recent Advances in Diagnosis of Cancer.

J R Bhardwaj1.   

Abstract

Entities:  

Keywords:  Markers; Molecular; Oncology

Year:  2011        PMID： 27407728      PMCID： PMC4923002          DOI： 10.1016/S0377-1237(05)80002-4

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  6 in total

1.  Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis.

Authors:  Valia S Lestou; Olga Ludkovski; Joseph M Connors; Randy D Gascoyne; Wan L Lam; Douglas E Horsman
Journal:  Genes Chromosomes Cancer       Date:  2003-04       Impact factor: 5.006

Review 2.  Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy.

Authors:  Leslie K Diaz; Nour Sneige
Journal:  Adv Anat Pathol       Date:  2005-01       Impact factor: 3.875

3.  Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.

Authors:  Hazel B Nichols; Amy Trentham-Dietz; Richard R Love; John M Hampton; Pham Thi Hoang Anh; D Craig Allred; Syed K Mohsin; Polly A Newcomb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-01       Impact factor: 4.254

Review 4.  Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics.

Authors:  Guido Marcucci; Krzysztof Mrózek; Clara D Bloomfield
Journal:  Curr Opin Hematol       Date:  2005-01       Impact factor: 3.284

5.  Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis.

Authors:  Wen Xie; David L Rimm; Yong Lin; Weichung J Shih; Michael Reiss
Journal:  Cancer J       Date:  2003 Jul-Aug       Impact factor: 3.360

6.  Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes.

Authors:  J Däbritz; J Hänfler; R Preston; J Stieler; H Oettle
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.